MedPath

SINGAPORE GENERAL HOSPITAL

🇸🇬Singapore
Ownership
-
Established
1821-01-01
Employees
-
Market Cap
-
Website
http://www.sgh.com.sg/Pages/default.aspx

Clinical Trials

241

Active:10
Completed:107

Trial Phases

5 Phases

Phase 1:12
Phase 2:30
Phase 3:17
+2 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (178 trials with phase data)• Click on a phase to view related trials

Not Applicable
107 (60.1%)
Phase 2
30 (16.9%)
Phase 3
17 (9.6%)
Phase 1
12 (6.7%)
Phase 4
12 (6.7%)

Pain Relief in Women Undergoing Oocyte Retrieval (OR) With Electro-acupuncture (EA) or Conscious Sedation (CS) in a Single Assisted Reproduction Centre.

Not Applicable
Completed
Conditions
Pain Intensity Assessment
First Posted Date
2025-06-27
Last Posted Date
2025-06-27
Lead Sponsor
Singapore General Hospital
Target Recruit Count
60
Registration Number
NCT07041632
Locations
🇸🇬

Centre for Assisted Reproduction, Singapore, Singapore

Trial of Mobile External Defibrillator for Out-of-hospital Cardiac Arrest in Singapore.

Not Applicable
Not yet recruiting
Conditions
Out-of-hospital Cardiac Arrest (OHCA)
First Posted Date
2025-06-27
Last Posted Date
2025-06-27
Lead Sponsor
Singapore General Hospital
Target Recruit Count
1000
Registration Number
NCT07042061

A Randomised Controlled Trial Comparing the Efficacy of Ultrasound-guided Hydrodilatation With Intra-articular Corticosteroid Injection in the Treatment of Adhesive Capsulitis.

Not Applicable
Completed
Conditions
Adhesive Capsulitis, Shoulder
First Posted Date
2025-05-23
Last Posted Date
2025-05-23
Lead Sponsor
Singapore General Hospital
Target Recruit Count
20
Registration Number
NCT06987929
Locations
🇸🇬

Autoimmunity and Rheumatology Centre, Singapore, Singapore

Be Right! Back: An Artificial Intelligence Enabled Mobile Application for Patients With Low Back Pain

Not yet recruiting
Conditions
Low Back Pain
First Posted Date
2025-05-15
Last Posted Date
2025-05-15
Lead Sponsor
Singapore General Hospital
Target Recruit Count
120
Registration Number
NCT06973915
Locations
🇸🇬

Singapore General Hospital, Singapore, Singapore

Assessing the Feasibility of the Patient-Reported Outcomes Based Model for Community Care of Patients With Axial Spondyloarthritis Via a Type 1 Pilot Hybrid Effectiveness-Implementation Trial Using the RE-AIM Framework

Not Applicable
Not yet recruiting
Conditions
Axial Spondyloarthritis
First Posted Date
2025-05-13
Last Posted Date
2025-05-13
Lead Sponsor
Singapore General Hospital
Target Recruit Count
70
Registration Number
NCT06968247
Locations
🇸🇬

Singapore General Hospital, Singapore, Singapore

  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 48
  • Next

News

Groundbreaking Histotripsy Cancer Treatment Trials to Begin in Singapore by 2025

• Singapore will commence clinical trials of histotripsy, a non-invasive ultrasound-based cancer treatment that uses microbubbles to destroy tumors without surgery or radiation, starting in the second half of 2025. • The Li Ka Shing Foundation and Temasek Trust have committed S$12 million to bring two histotripsy machines to Singapore, with initial trials focusing on 40 liver cancer patients before expanding to kidney and pancreatic cancers. • Histotripsy, which received FDA approval for liver tumors in October 2023, has already treated approximately 50 cancer patients in Hong Kong and over 1,000 in the US, with researchers noting its potential to stimulate immune responses against non-targeted tumors.

© Copyright 2025. All Rights Reserved by MedPath